Bionano Genomics, Inc. (BNGO) Free cash flow 2017–2025
Bionano Genomics, Inc. (BNGO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.3MFY2025 · since FY2017: -$21.8M → -$16.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.3M | +76.3% |
| FY2024 | -$69.0M | +45.6% |
| FY2023 | -$126.9M | +0.3% |
| FY2022 | -$127.2M | — |
| FY2020 | -$38.3M | -29.5% |
| FY2019 | -$29.6M | -45.9% |
| FY2018 | -$20.3M | +7.1% |
| FY2017 | -$21.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice